- Title
- Risk of opioid misuse in people with cancer and pain and related clinical considerations: a qualitative study of the perspectives of Australian general practitioners
- Creator
- Luckett, Tim; Newton-John, Toby; Phillips, Jane; Holliday, Simon; Giannitrapani, Karleen; Powell-Davies, Gawaine; Lovell, Melanie; Liauw, Winston; Rowett, Debra; Pearson, Sallie-Anne; Raymond, Bronwyn; Heneka, Nicole; Lorenz, Karl
- Relation
- BMJ Open Vol. 10, Issue 2, no. e034363
- Publisher Link
- http://dx.doi.org/10.1136/bmjopen-2019-034363
- Publisher
- British Medical Journal (BMJ)
- Resource Type
- journal article
- Date
- 2020
- Description
- Objective: To explore the perspectives of general practitioners (GPs) concerning the risk of opioid misuse in people with cancer and pain and related clinical considerations. Design: A qualitative approach using semistructured telephone interviews. Analysis used an integrative approach. Setting: Primary care. Participants: Australian GPs with experience of prescribing opioids for people with cancer and pain. Results: Twenty-two GPs participated, and three themes emerged. Theme 1 (Misuse is not the main problem) contextualised misuse as a relatively minor concern compared with pain control and toxicity, and highlighted underlying systemic factors, including limitations in continuity of care and doctor expertise. Theme 2 (‘A different mindset’ for cancer pain) captured participants’ relative comfort in prescribing opioids for pain in cancer versus non-cancer contexts, and acknowledgement that compassion and greater perceived community acceptance were driving factors, in addition to scientific support for mechanisms and clinical efficacy. Participant attitudes towards prescribing for people with cancer versus non-cancer pain differed most when cancer was in the palliative phase, when they were unconcerned by misuse. Participants were equivocal about the risk–benefit ratio of long-term opioid therapy in the chronic phase of cancer, and were reluctant to prescribe for disease-free survivors. Theme 3 (‘The question is always, ‘how lazy have you been?’) captured participants’ acknowledgement that they sometimes prescribed opioids for cancer pain as a default, easier option compared with more holistic pain management. Conclusions: Findings highlight the role of specific clinical considerations in distinguishing risk of opioid misuse in the cancer versus non-cancer population, rather than diagnosis per se. Further efforts are needed to ensure continuity of care where opioid prescribing is shared. Greater evidence is needed to guide opioid prescribing in disease-free survivors and the chronic phase of cancer, especially in the context of new treatments for metastatic disease.
- Subject
- general practioners (GPs); opioid misuse; cancer; pain; SDG 3; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1462893
- Identifier
- uon:46587
- Identifier
- ISSN:2044-6055
- Rights
- © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
- Language
- eng
- Full Text
- Reviewed
- Hits: 5251
- Visitors: 5368
- Downloads: 124
Collections
Goal 3: Good Health and Well-Being
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | ATTACHMENT02 | Publisher version (open access) | 336 KB | Adobe Acrobat PDF | View Details Download |